Investors Eye Abeona Therapeutics: Zevaskyn Partnership Fuels Gene‑Therapy Growth Ahead of FDA Push
Explore Abeona Therapeutics’ volatile stock, Zevaskyn gene therapy progress, and partnership strategy—insightful for investors eyeing biotech growth.
- ABEONA THERAPEUTICS INC
- United States
- Health Care
- Pharmaceuticals, Biotechnology & Life Sciences
- AI generated
3 minutes to read